Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
06/2003
06/25/2003CN1425653A 2,4,5-trisubstituted imidazole compounds and its preparing process and pharmaceutical use
06/25/2003CN1425365A 2,5-diaminopyridine oxidation color display alkali for dyeing keratin fibre
06/24/2003US6583288 Hydantoin-containing glucokinase activators
06/24/2003US6583282 Formation of a urea by reacting an aromatic carbamate with a aromatic amine
06/24/2003US6583166 Fewer side effects than D2 receptor antagonist neuroleptics; cardiovascular, kidney, central nervous system disorders; 3-(3-((4-methyl-5-phenyl-4H-1,2,4-triazol-3-yl)sulfanyl) propyl)-1,3,3a,4,5,9b-hexahydro-2H-benzo(e)indol-2-one
06/24/2003US6583162 Chronic dermal ulcers, wound healing
06/24/2003US6583156 Particularly adenosine A2A receptors; neurodegenerative disorders; 2,8-bis(trifluoromethyl)-alpha -(3-thienyl)-4-quinolinemethanol
06/24/2003US6583148 Neurodegenerative or other neurological disorders; enhancing the effect of nerve growth factor; 2-Amino-5-(4-chlorophenoxy)-4-trans-4-hydroxycyclohexylamino) pyrimidine
06/24/2003US6583137 Protease inhibitors
06/24/2003US6582351 Benzimidazole heterocyclic compounds having pharmacological activities, and their use as a medicament for treatment or prevention of diseases mediated by cGMP-PDE
06/24/2003CA2288910C Pyrazolopyrimidinones for sexual dysfunction
06/24/2003CA2066094C Fused heterocyclic compounds, their production and use
06/19/2003WO2003050261A2 (1-phenyl-2-heteroaryl)ethyl-guanidine compounds as inhibitors of mitochondrial f1f0 atp hydrolase
06/19/2003WO2003050109A1 Alanyl-piperidine heterocyclic derivatives useful against cardiovascular diseases
06/19/2003WO2003050108A1 Salt forms of e-2-methoxy-n-(3-(4-(3-methyl-pyridin-3-yloxy)-phenylamino)-quinazolin-6-yl)-allyl)-acetamide, its preparation and its use against cancer
06/19/2003WO2003050107A1 New generation triple-targeting, chiral, broad-spectrum antimicrobial 7-substituted piperidino-quinolone carboxylic acid derivatives, their preparation, compositions and use as medicaments
06/19/2003WO2003050099A1 Phenylalkynes
06/19/2003WO2003050090A1 3-cyanoquinolines as inhibitors of egf-r and her2 kinases
06/19/2003WO2003050088A1 Substituted heterocyclic carboxamides with antithrombotic activity
06/19/2003WO2003049742A1 Method for administering birb 796 bs
06/19/2003WO2003049740A1 Quinazoline derivatives for the treatment of abnormal cell growth
06/19/2003WO2003049739A1 Pyrimidine-based compounds useful as gsk-3 inhibitors
06/19/2003WO2003049737A1 Chemical compounds
06/19/2003WO2003049735A1 Certain glycine derivatives as factor xa inhibitors for use in the treatment of thrombotic disorders
06/19/2003WO2003049702A2 Vanilloid receptor ligands and their use in treatments
06/19/2003WO2003049678A2 Mitotic kinesin inhibitors
06/19/2003WO2003049542A1 Pyrazoles-pyrimidine fungicides
06/19/2003WO2003028650A3 Benzimidazolidinone derivatives as muscarinic agents
06/19/2003US20030114668 Aroyl-piperazine derivatives, their preparation and their use as tachykinin antagonists
06/19/2003US20030114667 Reacting heterocycle such as 2-cyanoiminothiazolidine with base in presence of diluent, and subsequently reacting product with mixture of 2-chloro-5-chloromethylpyridine and 2-chloro-5-methylpyridine and corresponding hydrochlorides
06/19/2003US20030114666 Antibacterial agents
06/19/2003US20030114649 Plant fungicide
06/19/2003US20030114517 Substituted urea neuropeptide Y Y5 receptor antagonists
06/19/2003US20030114508 Fused imidazolium derivatives
06/19/2003US20030114499 Antiarrhythmic agents for the treatment and prophylaxis of atrial arrhythmias, atrial fibrillation (AF) or atrial flutter; potassium channel modulators, beta-blocker
06/19/2003US20030114489 Asthma therapy; antiallergens; antiinflammatory agents
06/19/2003US20030114487 Enantiomers of 6-[(4-chloro-phenyl)- hydroxy-(3-methyl-3h-imidazol-4-yl)-methyl]-4-[3-(3-hydroxy-3-methyl-but-1-ynyl)-phenyl]-1- methyl-1h-quinolin-2-one and salts thereof, useful in the treatment of cancer
06/19/2003US20030114472 Viricides
06/19/2003US20030114465 Substituted imidazole neuropeptide Y Y5 receptor antagonists
06/19/2003US20030114456 Antiinflammatory agents, analgesics, antipyretics
06/19/2003US20030114455 Sexual disorders
06/19/2003US20030114448 Inhibitors of factor Xa
06/19/2003US20030114447 Controlling apoptosis; central nervous system disorders
06/19/2003US20030114446 Induce immunology response
06/19/2003US20030114445 Bactericides
06/19/2003US20030114443 Viricides, Aids therapy
06/19/2003US20030114437 Protease inhibitors
06/19/2003US20030114436 3-substituted piperidines comprising urea functionality, and methods of use thereof
06/19/2003US20030114311 Such as 5,6-dichloropyridine-2-carboxylic acid-N-oxide for preemergence application
06/19/2003US20030113336 A compound comprising a targeting moiety binds to a chelator, quinolone antibiotics, imaging tumors in a patient, treating cancer
06/19/2003CA2469893A1 Phenylalkynes
06/19/2003CA2469889A1 Salt forms of e-2-methoxy-n-(3-(4-(3-methyl-pyridin-3-yloxy)-phenylamino)-quinazolin-6-yl)-allyl)-acetamide, its preparation and its use against cancer
06/19/2003CA2469670A1 Quinazoline derivatives for the treatment of abnormal cell growth
06/19/2003CA2469316A1 Pyrimidine-based compounds useful as gsk-3 inhibitors
06/19/2003CA2468544A1 Vanilloid receptor ligands
06/19/2003CA2468266A1 Substituted bicyclic pyrimidinones as a mitotic kinesin ksp inhibitors
06/19/2003CA2468190A1 New generation triple-targeting, chiral, broad-spectrum antimicrobial 7-substituted piperidino-quinolone carboxylic acid derivatives, their preparation, compositions and use as medicaments
06/19/2003CA2467573A1 3-cyanoquinolines as inhibitors of egf-r and her2 kinases
06/19/2003CA2465759A1 Method for administering birb 796 bs
06/19/2003CA2460122A1 Pyrazoles-pyrimidine fungicides
06/18/2003EP1319659A1 Pyridazinones and triazinones and medicinal use thereof
06/18/2003EP1319643A2 Macromolecular HALS with a definite molecular weight
06/18/2003EP1318997A1 Pyrazole compounds useful as protein kinase inhibitors
06/18/2003EP1318996A2 Substituted imidazoles as dual histamine h1 and h3 agonists or antagonists
06/18/2003EP1318995A2 Pyridinone and pyridinethione derivatives having hiv inhibiting properties
06/18/2003EP1318994A2 Substituted imidazoles as dual histamine h1 and h3 agonists or antagonists
06/18/2003EP1318993A2 Substituted imidazoles as dual histamine h1 and h3 agonists or antagonists
06/18/2003EP1318992A1 Imidazole derivatives as raf kinase inhibitors
06/18/2003EP1318988A2 Ligands for monoamine receptors and transporters, and methods of use thereof (neurotransmission)
06/18/2003EP1318984A1 4-amino-quinazolines
06/18/2003EP1318983A2 Substituted imidazoles as dual histamine h1 and h3 agonists or antagonists
06/18/2003EP1318981A2 Quinoline and quinazoline derivatives as ligands for the neuropeptide y receptor
06/18/2003EP1318980A2 Hydroxamate derivatives useful as deacetylase inhibitors
06/18/2003EP1318978A2 N-acylsulfonamide apoptosis promoters
06/18/2003EP1318977A1 Substituted phenylcyclohexane carboxylic acid amides and the use thereof
06/18/2003EP1318814A2 Triazole compounds useful as protein kinase inhibitors
06/18/2003EP1318811A1 Cyclopentyl modulators of chemokine receptor activity
06/18/2003EP1318802A2 Substituted hydrazine derivatives
06/18/2003EP1115704B1 Novel substituted indolinones with an inhibitory effect on various kinases and cyclin/cdk complexes
06/18/2003EP1102747B1 Crystalline forms of osanetant
06/18/2003EP1075475B1 Heterocyclic carboxamide derivatives as inhibitors of nitric oxide production
06/18/2003EP0923571B1 Trisubstituted pyridine compounds for herbicidal use
06/18/2003EP0815859B1 Intimal thickening inhibitors
06/18/2003CN1425013A Phenyl substituted 4-hydroxy tetrahydropyridone
06/18/2003CN1425009A Arylmethyl-carbonylamino-thiazole derivatives and their use as antitumor agents
06/18/2003CN1425008A 3-aminoquinazolin-2, 4-dione antibacterial agents
06/18/2003CN1425004A N-substituted metal proteinase inhibitor with heterocyclic side chain
06/18/2003CN1425002A Pyrrolidine and piperidine derivatives and their use for treatment of neurodegenerative disorders
06/18/2003CN1424911A 焦虑方法 Anxiety method
06/18/2003CN1111561C Compositions for the stabilization of synthetic polymers and its application
06/18/2003CN1111529C Piperazino derivatives as neurokinin antagonists
06/18/2003CN1111528C Piperazino derivatives as neurokinin antagonists
06/18/2003CN1111524C Process for manufacture of pyridine-2,3-dicarboxylate compounds and intermediates
06/18/2003CN1111523C Method for the catalytic production of substituted dipyridyl derivatives
06/18/2003CN1111406C Anti-HIV composition containing imidazole derivative
06/17/2003US6579986 Preparation of quinoline-substituted carbonate and carbamate derivatives
06/17/2003US6579983 5-cyano-2-aminopyrimidine derivatives
06/17/2003US6579892 Affective disorders; neurotic, stress and somatoform disorders and psychoses, e.g. schizophrenia 3-(3-(6-Methyl-1,2,3,4-tetrahydronaphth-2-ylamino)propylmercap to) -4-methyl-5-phenyl-1,2,4(4H)-triazole
06/17/2003US6579887 Alkynyl-substituted quinolin-2-one derivatives useful as anticancer agents
06/17/2003US6579886 Ionotropic glutamate receptors; 6-((4-carboxylic acid-1H-imidazol-1-yl)methyl)-1,2,3,4,4a,5,6,7,8,8a-decahydroisoquinoline-3 -carboxylic acid
1 ... 696 697 698 699 700 701 702 703 704 705 706 707 708 709 710 711 712 713 714 715 716 ... 1080